How do compliance, convenience, and tolerability affect blood pressure goal rates?

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Uncontrolled hypertension presents a significant global health burden.
• Poor patient compliance with antihypertensive medications contributes to suboptimal blood pressure control.
• Factors influencing non-compliance include asymptomatic disease, medication side effects, treatment complexity, and high pill burden.

Purpose of the Study:

• To highlight the importance of addressing patient compliance in hypertension management.
• To introduce fixed-dose combination (FDC) therapy as a strategy to simplify treatment regimens.
• To present triple FDC therapy as a novel approach for improving blood pressure control in challenging cases.

Main Methods:

• Review of existing literature on hypertension management and patient compliance.
• Analysis of treatment guidelines advocating for simplified therapeutic strategies.
• Focus on the role of triple fixed-dose combination therapy in clinical practice.

Main Results:

• Good patient compliance is linked to improved blood pressure control and better health outcomes.
• Fixed-dose combination therapy simplifies treatment regimens for patients requiring multiple antihypertensive agents.
• Triple FDC therapy, combining an angiotensin receptor blocker, calcium channel blocker, and thiazide diuretic, shows promise for hard-to-treat hypertension.

Conclusions:

• Improving patient compliance is crucial for effective hypertension management.
• Simplified treatment strategies, such as FDC therapy, are valuable for enhancing adherence.
• Triple FDC therapy represents a promising advancement for achieving blood pressure goals in complex hypertensive patients.